Home > Pressrelease > Biliary Stents Market size to surpass $699 Mn by 2032

Biliary Stents Market size to surpass $699 Mn by 2032

  • Published Date: January 19, 2023

Biliary Stents Market size is anticipated to reach USD 699 million by 2032, as per a new research report announced by Global Market Insights Inc.

Number of people being diagnosed with gallstones and other biliary disorders is increasing steadily, contributing to the rise in demand for minimally invasive surgical procedures. The awareness about the diagnosis and treatment of a wide range of gastrointestinal diseases is also growing at a considerable rate. Advanced technologies are thus being unveiled to improve patient outcomes and boost efficiency while carrying out stenting procedures. Consequently, benefits such as quick recovery and lower risk of infection are likely to bolster the preference for biliary stent implantation through minimally invasive operations.

However, one of the key factors impeding the biliary stents market growth is the high cost of plastic bile duct stents. Polymer stents are mainly made of teflon and polyethylene. The wide availability of a variety of configurations and economical prices result in high demand for polymer stents. However, as these stents need faster replacement as compared to their metal counterparts, the total cost of treatment may increase hampering the market development to some extent.

Minimal risks post placement to improve usage of metal stents

Biliary stents market revenue from the metal stent segment was valued at more than USD 253 million in 2022. These stents are thin-wired, mesh-like tubes that come in several lengths and diameters. Metal stents offer better patency, minimal slippage post-placement, and have a longer lifespan. Self-expandable stents have a post expansion diameter ranging from 6 to 10 mm. The high occurrence of diseases affecting the bile duct, such as biliary leaks, pancreatic cancer, and gallstones will bolster the usage of metal stents.

Browse key industry insights spread across 139 pages with 171 market data tables & 10 figures & charts from the report,Biliary Stents Market Size By Type (Metal Stents, Polymer Stents), Application (Bilio-pancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones), End-use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:

Biliary stents to emerge as preferred gallstones treatment solution

Gallstones segment held over 52% growth rate of biliary stents industry in 2022. This is attributed to unhealthy lifestyle changes, such as the adoption of sedentary lifestyles and a family history of gallstones. Although termed as non-fatal, gallstones can create blockages in the biliary tract, which is why it is essential to manage them effectively. Patients are also becoming aware of the availability of innovative treatments for biliary system diseases, thereby spurring the usage of biliary stents as a solution for gallstones.

Integration of advanced healthcare infrastructure will increase patients’ preference for biliary disease treatment in hospitals

Hospital segment gain around 72.5% share of the global biliary stents market in 2022. This can be credited to the growing prevalence of biliary disorders and a rising number of patients opting for stenting procedures. Technologically advanced healthcare infrastructure is also being developed. . These factors, alongside the widespread availability of skilled medical professionals, can improve the overall quality of consulting, diagnosis, treatment, and care provided by hospitals, thereby contributing to biliary stent industry expansion.

Rising elderly population to drives biliary stent progression in North America

North America biliary stents market is witnessing a notable increase in the percentage of its elderly population, which is at high risk of contracting a variety of chronic ailments. These diseases include gallstones, pancreatic cancer, and other harmful obstructions. The growing prevalence of such conditions is likely to amplify progress for effective biliary treatments, including stents, and in turn, strengthen the regional market trends.

Product launch initiatives from key players to define industry landscape

Some of the major participants in the biliary stents industry include Boston Scientific, B Braun Melsungen, Olympus Corporation, M.I Tech, CONMED Corporation, C.R. Bard (Becton, Dickinson & Company), ENDO-FLEX GmbH, Medtronic plc, and Cardinal Health, among many others. These players are exploring various strategies, including novel product launches, to establish a firm presence in the global market.

Authors: Sumant Ugalmugle, Rupali Swain